* ESCAgenetics Corp., of San Carlos, Calif., received a U.S. patentcovering genetically modified "C" arabica coffee cells and the processused to produce genetically modified coffee plants and seeds from thecells.* Cypros Pharmaceutical Corp., Carlsbad, Calif., has received two U.S.patents. One covers CPC-402 and related compounds that increaselevels of adenosine and the other covers use of CPC-501 for cerebralischemia.* Somatix Therapy Corp., of Alameda, Calif., has received a Europeanpatent for genetically modified endothelial cells for development oftherapeutics. Endothelial cells line the blood and lymph vessels, theheart chambers and other cavities inside the body.
(c) 1997 American Health Consultants. All rights reserved.